ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,462,896, issued on Nov. 4, was assigned to LUNIT INC. (Seoul, South Korea).

"Method and system for predicting response to immune anticancer drugs" was invented by Donggeun Yoo (Seoul, South Korea), Chanyoung Ock (Seoul, South Korea) and Kyunghyun Paeng (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method, performed by at least one computing device, for predicting a response to an immune checkpoint inhibitor. The method includes receiving a first pathology slide image, detecting one or more target items in the first pathology slide image, determining at least one of an immune phenotype of at least s...